Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARA 290 in prediabetes or drug-naive type 2 diabetes
2012-003207-35Phase 2Completed
- Sponsor
- Karolinska University Hospital
- Start
- Jul 2013
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial in prediabetes and type 2 diabetes mellitus (T2DM) comparing ARA 290 with Placebo (2 arms). Primary endpoint: Glucose tolerance by oral glucose tolerance test. Started Jul 2013; status: completed.
02
Drugs
cibinetide
03
Conditions
prediabetestype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2012-003207-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003207-35.